Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Microglia‐Derived Vitamin D Binding Protein Mediates Synaptic Damage and Induces Depression by Binding to the Neuronal Receptor Megalin

Source: Article title. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Animal research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

To establish a rodent model of depression, 5 to 6 weeks old male mice were randomly divided into CUMS and control groups.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Microglia‐Derived Vitamin D Binding Protein Mediates Synaptic Damage and Induces Depression by Binding to the Neuronal Receptor Megalin

Study design awaiting verification · Advanced Science · 2024

Original publication title

Microglia‐Derived Vitamin D Binding Protein Mediates Synaptic Damage and Induces Depression by Binding to the Neuronal Receptor Megalin

Yan Kong; Xian Zhang; Ling Li; Te Zhao; Zihan Huang; Aini Zhang; Yun Sun; Jiao Jiao; Gaojia Zhang; Mengyu Liu; Yijun Han; Linfeng Yang; Zhijun Zhang

© 2024 The Author(s). Advanced Science published by Wiley‐VCH GmbH

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Abstract

Vitamin D binding protein (VDBP) is a potential biomarker of major depressive disorder (MDD). This study demonstrates for the first time that VDBP is highly expressed in core emotion‐related brain regions of mice susceptible to chronic unpredictable mild stress (CUMS). Specifically, the overexpression of microglia (MG)‐derived VDBP in the prelimbic leads to depression‐like behavior and aggravates CUMS‐induced depressive phenotypes in mice, whereas conditional knockout of MG‐derived VDBP can reverse both neuronal damage and depression‐like behaviors. Mechanistically, the binding of MG‐derived VDBP with the neuronal receptor megalin mediates the downstream SRC signaling pathway, leading to neuronal and synaptic damage and depression‐like behaviors.

These events may be caused by biased activation of inhibitory neurons and excitatory: inhibitory imbalance. Importantly, this study has effectively identified MG‐derived VDBP as a pivotal mediator in the interplay between microglia and neurons via its interaction with the neuronal receptor megalin and intricate downstream impacts on neuronal functions, thus offering a promising therapeutic target for MDD.

Authors’ abstract

Abstract

Vitamin D binding protein (VDBP) is a potential biomarker of major depressive disorder (MDD). This study demonstrates for the first time that VDBP is highly expressed in core emotion‐related brain regions of mice susceptible to chronic unpredictable mild stress (CUMS). Specifically, the overexpression of microglia (MG)‐derived VDBP in the prelimbic leads to depression‐like behavior and aggravates CUMS‐induced depressive phenotypes in mice, whereas conditional knockout of MG‐derived VDBP can reverse both neuronal damage and depression‐like behaviors. Mechanistically, the binding of MG‐derived VDBP with the neuronal receptor megalin mediates the downstream SRC signaling pathway, leading to neuronal and synaptic damage and depression‐like behaviors.

These events may be caused by biased activation of inhibitory neurons and excitatory: inhibitory imbalance. Importantly, this study has effectively identified MG‐derived VDBP as a pivotal mediator in the interplay between microglia and neurons via its interaction with the neuronal receptor megalin and intricate downstream impacts on neuronal functions, thus offering a promising therapeutic target for MDD.

Publication and source details

Original title: Microglia‐Derived Vitamin D Binding Protein Mediates Synaptic Damage and Induces Depression by Binding to the Neuronal Receptor Megalin

Yan Kong; Xian Zhang; Ling Li; Te Zhao; Zihan Huang; Aini Zhang; Yun Sun; Jiao Jiao; Gaojia Zhang; Mengyu Liu; Yijun Han; Linfeng Yang; Zhijun Zhang

Advanced Science · 2024

* E‐mail: ykong@seu.edu.cn; zhijunzhang@seu.edu.cn
© 2024 The Author(s). Advanced Science published by Wiley‐VCH GmbHhttps://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.China Science and Technology Innovation 2030 ‐ Major Project2022ZD02117012021ZD0200700National Natural Science Foundation of China 10.13039/501100001809821300428183004082371532Shenzhen Science and Technology Serial FundsGJHZ20210705141400002KCXFZ20211020164543006JCYJ20220818101615033ZDSYS20220606100606014KQTD20221101093608028

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T02:29:38.770597+00:00

DOI: 10.1002/advs.202410273 · PMC11809382